What is the consensus rating for AbbVie stock?

AbbVie has received a consensus rating of Hold. The company's average rating score is 2.36, and is based on 6 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $158.78, AbbVie has a forecasted downside of 1.8% from its current price of $161.61.

What is the history of AbbVie Inc. (ABBV) stock?

AbbVie has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. AbbVie Inc. is a US-based biopharma company with global operations. The company originated as the bio-pharma segment of Abbott Laboratories and was spun off in late 2012.

What is Abbvie Inc.'s stock symbol?

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.